Journal of Cachexia Sarcopenia and Muscle-期刊论坛，投稿经验-MedSci.cn

[GetPortalCommentsPageByObjectIdResponse(id=2237908, encodeId=9555223e90817, content=审稿速度:24.0 | 投稿命中率:25.0 偏重的研究方向：肌萎缩 经验分享：9.28投，10.10 with editor ，10.27催了，10.28回复在找审稿人，10.30又with editor 现在11.20 还是with editor什么情况。。。。到底要多久啊。。即将两个月, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=22, replyNumber=29, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ba1a8284909, createdName=ms3000001983661864, createdTime=Wed Nov 20 00:08:49 CST 2024, time=2024-11-20, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2238728, encodeId=3cde2238e28fd, content=一直 submitted 什么情况 11.15投的没变过, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=8, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b6e09260819, createdName=ms4000000384958423, createdTime=Sat Nov 23 19:21:58 CST 2024, time=2024-11-23, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2218493, encodeId=a36e2218493c2, content=偏重的研究方向：低肌肉质量;临床 经验分享：记录一下，8月2号投的，现在是 submit to journal, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=54, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=13995143031, createdName=1467de12m97暂无昵称, createdTime=Mon Aug 05 01:43:34 CST 2024, time=2024-08-05, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2240088, encodeId=54ab224008886, content=投稿命中率:25.0 偏重的研究方向：老年医学;分子机理 经验分享：2024.10.11投稿 with editor 2024.11.19 under review 到现在一点动静都没有……真的是所有投稿都送审吗……, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=7, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=68998321751, createdName=ms2000000373480608, createdTime=Sat Nov 30 18:53:30 CST 2024, time=2024-11-30, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2239393, encodeId=8d2e2239393f4, content=审稿速度:3.0 | 投稿命中率:50.0 经验分享：JCSM是一本中科院一区的顶级期刊，专注于恶病质、肌少症以及相关领域的研究。 审稿周期通常较长，平均需要16周左右的时间。 在提交稿件时，可以考虑附上一封详细的投稿信（个人觉得有点帮助） 要注意的是如大修，在修改时详细回复每项评论，并附上修改说明。 大家还了解哪些可以继续补充 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=30, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=520e8539624, createdName=ms2000001788822131, createdTime=Tue Nov 26 22:43:18 CST 2024, time=2024-11-26, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2239914, encodeId=2af52239914c2, content=审稿速度:12.0 | 投稿命中率:5.0 经验分享：3月份投稿 6月份大修 8月初修回到现在一直在UR 是什么情况会被拒稿吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=6, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/img/user_icon.png, createdBy=1e3e9045656, createdName=ms6000000691767799, createdTime=Fri Nov 29 13:08:07 CST 2024, time=2024-11-29, status=1, ipAttribution=新加坡), GetPortalCommentsPageByObjectIdResponse(id=2239303, encodeId=aabb2239303fc, content=审稿速度:3.0 偏重的研究方向：消化道肿瘤 经验分享：可怕这个杂志是所有文章都送审吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=7, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/img/user_icon.png, createdBy=1e3e9045656, createdName=ms6000000691767799, createdTime=Tue Nov 26 14:26:03 CST 2024, time=2024-11-26, status=1, ipAttribution=新加坡), GetPortalCommentsPageByObjectIdResponse(id=2238655, encodeId=f4f8223865586, content=审稿速度:3.0 | 投稿命中率:25.0 经验分享：投稿3个月了 UR时间都变了好几次了到底要多久才能回来, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=13, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/img/user_icon.png, createdBy=1e3e9045656, createdName=ms6000000691767799, createdTime=Sat Nov 23 13:38:13 CST 2024, time=2024-11-23, status=1, ipAttribution=新加坡), GetPortalCommentsPageByObjectIdResponse(id=2230225, encodeId=6e9d223022598, content=刚投稿，做的多中心的肌少症预测模型，希望审稿人手下留情。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3ea29491375, createdName=ms2000001231894997, createdTime=Thu Oct 10 22:57:21 CST 2024, time=2024-10-10, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=2229607, encodeId=2aab222960e2b, content=偏重的研究方向：肌肉减少症;临床 经验分享：记录一下，9.26投的，10.1变成with editor，今天10.7，还在with editor, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=33, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=8f372177652, createdName=1206696em63(暂无昵称), createdTime=Mon Oct 07 09:55:55 CST 2024, time=2024-10-07, status=1, ipAttribution=湖北省)]

2024-11-20 ms3000001983661864 来自北京

审稿速度:24.0 | 投稿命中率:25.0
偏重的研究方向：肌萎缩
经验分享：9.28投，10.10 with editor ，10.27催了，10.28回复在找审稿人，10.30又with editor 现在11.20 还是with editor什么情况。。。。到底要多久啊。。即将两个月

22 29

展开29条回复

[GetPortalCommentsPageByObjectIdResponse(id=2237908, encodeId=9555223e90817, content=审稿速度:24.0 | 投稿命中率:25.0 偏重的研究方向：肌萎缩 经验分享：9.28投，10.10 with editor ，10.27催了，10.28回复在找审稿人，10.30又with editor 现在11.20 还是with editor什么情况。。。。到底要多久啊。。即将两个月, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=22, replyNumber=29, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ba1a8284909, createdName=ms3000001983661864, createdTime=Wed Nov 20 00:08:49 CST 2024, time=2024-11-20, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2238728, encodeId=3cde2238e28fd, content=一直 submitted 什么情况 11.15投的没变过, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=8, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b6e09260819, createdName=ms4000000384958423, createdTime=Sat Nov 23 19:21:58 CST 2024, time=2024-11-23, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2218493, encodeId=a36e2218493c2, content=偏重的研究方向：低肌肉质量;临床 经验分享：记录一下，8月2号投的，现在是 submit to journal, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=54, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=13995143031, createdName=1467de12m97暂无昵称, createdTime=Mon Aug 05 01:43:34 CST 2024, time=2024-08-05, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2240088, encodeId=54ab224008886, content=投稿命中率:25.0 偏重的研究方向：老年医学;分子机理 经验分享：2024.10.11投稿 with editor 2024.11.19 under review 到现在一点动静都没有……真的是所有投稿都送审吗……, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=7, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=68998321751, createdName=ms2000000373480608, createdTime=Sat Nov 30 18:53:30 CST 2024, time=2024-11-30, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2239393, encodeId=8d2e2239393f4, content=审稿速度:3.0 | 投稿命中率:50.0 经验分享：JCSM是一本中科院一区的顶级期刊，专注于恶病质、肌少症以及相关领域的研究。 审稿周期通常较长，平均需要16周左右的时间。 在提交稿件时，可以考虑附上一封详细的投稿信（个人觉得有点帮助） 要注意的是如大修，在修改时详细回复每项评论，并附上修改说明。 大家还了解哪些可以继续补充 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=30, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=520e8539624, createdName=ms2000001788822131, createdTime=Tue Nov 26 22:43:18 CST 2024, time=2024-11-26, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2239914, encodeId=2af52239914c2, content=审稿速度:12.0 | 投稿命中率:5.0 经验分享：3月份投稿 6月份大修 8月初修回到现在一直在UR 是什么情况会被拒稿吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=6, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/img/user_icon.png, createdBy=1e3e9045656, createdName=ms6000000691767799, createdTime=Fri Nov 29 13:08:07 CST 2024, time=2024-11-29, status=1, ipAttribution=新加坡), GetPortalCommentsPageByObjectIdResponse(id=2239303, encodeId=aabb2239303fc, content=审稿速度:3.0 偏重的研究方向：消化道肿瘤 经验分享：可怕这个杂志是所有文章都送审吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=7, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/img/user_icon.png, createdBy=1e3e9045656, createdName=ms6000000691767799, createdTime=Tue Nov 26 14:26:03 CST 2024, time=2024-11-26, status=1, ipAttribution=新加坡), GetPortalCommentsPageByObjectIdResponse(id=2238655, encodeId=f4f8223865586, content=审稿速度:3.0 | 投稿命中率:25.0 经验分享：投稿3个月了 UR时间都变了好几次了到底要多久才能回来, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=13, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/img/user_icon.png, createdBy=1e3e9045656, createdName=ms6000000691767799, createdTime=Sat Nov 23 13:38:13 CST 2024, time=2024-11-23, status=1, ipAttribution=新加坡), GetPortalCommentsPageByObjectIdResponse(id=2230225, encodeId=6e9d223022598, content=刚投稿，做的多中心的肌少症预测模型，希望审稿人手下留情。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3ea29491375, createdName=ms2000001231894997, createdTime=Thu Oct 10 22:57:21 CST 2024, time=2024-10-10, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=2229607, encodeId=2aab222960e2b, content=偏重的研究方向：肌肉减少症;临床 经验分享：记录一下，9.26投的，10.1变成with editor，今天10.7，还在with editor, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=33, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=8f372177652, createdName=1206696em63(暂无昵称), createdTime=Mon Oct 07 09:55:55 CST 2024, time=2024-10-07, status=1, ipAttribution=湖北省)]

2024-11-23 ms4000000384958423 来自广东省

一直 submitted 什么情况 11.15投的没变过

8 2

展开2条回复

[GetPortalCommentsPageByObjectIdResponse(id=2237908, encodeId=9555223e90817, content=审稿速度:24.0 | 投稿命中率:25.0 偏重的研究方向：肌萎缩 经验分享：9.28投，10.10 with editor ，10.27催了，10.28回复在找审稿人，10.30又with editor 现在11.20 还是with editor什么情况。。。。到底要多久啊。。即将两个月, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=22, replyNumber=29, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ba1a8284909, createdName=ms3000001983661864, createdTime=Wed Nov 20 00:08:49 CST 2024, time=2024-11-20, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2238728, encodeId=3cde2238e28fd, content=一直 submitted 什么情况 11.15投的没变过, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=8, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b6e09260819, createdName=ms4000000384958423, createdTime=Sat Nov 23 19:21:58 CST 2024, time=2024-11-23, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2218493, encodeId=a36e2218493c2, content=偏重的研究方向：低肌肉质量;临床 经验分享：记录一下，8月2号投的，现在是 submit to journal, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=54, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=13995143031, createdName=1467de12m97暂无昵称, createdTime=Mon Aug 05 01:43:34 CST 2024, time=2024-08-05, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2240088, encodeId=54ab224008886, content=投稿命中率:25.0 偏重的研究方向：老年医学;分子机理 经验分享：2024.10.11投稿 with editor 2024.11.19 under review 到现在一点动静都没有……真的是所有投稿都送审吗……, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=7, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=68998321751, createdName=ms2000000373480608, createdTime=Sat Nov 30 18:53:30 CST 2024, time=2024-11-30, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2239393, encodeId=8d2e2239393f4, content=审稿速度:3.0 | 投稿命中率:50.0 经验分享：JCSM是一本中科院一区的顶级期刊，专注于恶病质、肌少症以及相关领域的研究。 审稿周期通常较长，平均需要16周左右的时间。 在提交稿件时，可以考虑附上一封详细的投稿信（个人觉得有点帮助） 要注意的是如大修，在修改时详细回复每项评论，并附上修改说明。 大家还了解哪些可以继续补充 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=30, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=520e8539624, createdName=ms2000001788822131, createdTime=Tue Nov 26 22:43:18 CST 2024, time=2024-11-26, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2239914, encodeId=2af52239914c2, content=审稿速度:12.0 | 投稿命中率:5.0 经验分享：3月份投稿 6月份大修 8月初修回到现在一直在UR 是什么情况会被拒稿吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=6, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/img/user_icon.png, createdBy=1e3e9045656, createdName=ms6000000691767799, createdTime=Fri Nov 29 13:08:07 CST 2024, time=2024-11-29, status=1, ipAttribution=新加坡), GetPortalCommentsPageByObjectIdResponse(id=2239303, encodeId=aabb2239303fc, content=审稿速度:3.0 偏重的研究方向：消化道肿瘤 经验分享：可怕这个杂志是所有文章都送审吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=7, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/img/user_icon.png, createdBy=1e3e9045656, createdName=ms6000000691767799, createdTime=Tue Nov 26 14:26:03 CST 2024, time=2024-11-26, status=1, ipAttribution=新加坡), GetPortalCommentsPageByObjectIdResponse(id=2238655, encodeId=f4f8223865586, content=审稿速度:3.0 | 投稿命中率:25.0 经验分享：投稿3个月了 UR时间都变了好几次了到底要多久才能回来, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=13, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/img/user_icon.png, createdBy=1e3e9045656, createdName=ms6000000691767799, createdTime=Sat Nov 23 13:38:13 CST 2024, time=2024-11-23, status=1, ipAttribution=新加坡), GetPortalCommentsPageByObjectIdResponse(id=2230225, encodeId=6e9d223022598, content=刚投稿，做的多中心的肌少症预测模型，希望审稿人手下留情。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3ea29491375, createdName=ms2000001231894997, createdTime=Thu Oct 10 22:57:21 CST 2024, time=2024-10-10, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=2229607, encodeId=2aab222960e2b, content=偏重的研究方向：肌肉减少症;临床 经验分享：记录一下，9.26投的，10.1变成with editor，今天10.7，还在with editor, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=33, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=8f372177652, createdName=1206696em63(暂无昵称), createdTime=Mon Oct 07 09:55:55 CST 2024, time=2024-10-07, status=1, ipAttribution=湖北省)]

2024-08-05 1467de12m97暂无昵称来自江苏省

偏重的研究方向：低肌肉质量;临床
经验分享：记录一下，8月2号投的，现在是 submit to journal

54 11

展开11条回复

[GetPortalCommentsPageByObjectIdResponse(id=2237908, encodeId=9555223e90817, content=审稿速度:24.0 | 投稿命中率:25.0 偏重的研究方向：肌萎缩 经验分享：9.28投，10.10 with editor ，10.27催了，10.28回复在找审稿人，10.30又with editor 现在11.20 还是with editor什么情况。。。。到底要多久啊。。即将两个月, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=22, replyNumber=29, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ba1a8284909, createdName=ms3000001983661864, createdTime=Wed Nov 20 00:08:49 CST 2024, time=2024-11-20, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2238728, encodeId=3cde2238e28fd, content=一直 submitted 什么情况 11.15投的没变过, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=8, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b6e09260819, createdName=ms4000000384958423, createdTime=Sat Nov 23 19:21:58 CST 2024, time=2024-11-23, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2218493, encodeId=a36e2218493c2, content=偏重的研究方向：低肌肉质量;临床 经验分享：记录一下，8月2号投的，现在是 submit to journal, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=54, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=13995143031, createdName=1467de12m97暂无昵称, createdTime=Mon Aug 05 01:43:34 CST 2024, time=2024-08-05, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2240088, encodeId=54ab224008886, content=投稿命中率:25.0 偏重的研究方向：老年医学;分子机理 经验分享：2024.10.11投稿 with editor 2024.11.19 under review 到现在一点动静都没有……真的是所有投稿都送审吗……, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=7, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=68998321751, createdName=ms2000000373480608, createdTime=Sat Nov 30 18:53:30 CST 2024, time=2024-11-30, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2239393, encodeId=8d2e2239393f4, content=审稿速度:3.0 | 投稿命中率:50.0 经验分享：JCSM是一本中科院一区的顶级期刊，专注于恶病质、肌少症以及相关领域的研究。 审稿周期通常较长，平均需要16周左右的时间。 在提交稿件时，可以考虑附上一封详细的投稿信（个人觉得有点帮助） 要注意的是如大修，在修改时详细回复每项评论，并附上修改说明。 大家还了解哪些可以继续补充 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=30, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=520e8539624, createdName=ms2000001788822131, createdTime=Tue Nov 26 22:43:18 CST 2024, time=2024-11-26, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2239914, encodeId=2af52239914c2, content=审稿速度:12.0 | 投稿命中率:5.0 经验分享：3月份投稿 6月份大修 8月初修回到现在一直在UR 是什么情况会被拒稿吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=6, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/img/user_icon.png, createdBy=1e3e9045656, createdName=ms6000000691767799, createdTime=Fri Nov 29 13:08:07 CST 2024, time=2024-11-29, status=1, ipAttribution=新加坡), GetPortalCommentsPageByObjectIdResponse(id=2239303, encodeId=aabb2239303fc, content=审稿速度:3.0 偏重的研究方向：消化道肿瘤 经验分享：可怕这个杂志是所有文章都送审吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=7, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/img/user_icon.png, createdBy=1e3e9045656, createdName=ms6000000691767799, createdTime=Tue Nov 26 14:26:03 CST 2024, time=2024-11-26, status=1, ipAttribution=新加坡), GetPortalCommentsPageByObjectIdResponse(id=2238655, encodeId=f4f8223865586, content=审稿速度:3.0 | 投稿命中率:25.0 经验分享：投稿3个月了 UR时间都变了好几次了到底要多久才能回来, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=13, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/img/user_icon.png, createdBy=1e3e9045656, createdName=ms6000000691767799, createdTime=Sat Nov 23 13:38:13 CST 2024, time=2024-11-23, status=1, ipAttribution=新加坡), GetPortalCommentsPageByObjectIdResponse(id=2230225, encodeId=6e9d223022598, content=刚投稿，做的多中心的肌少症预测模型，希望审稿人手下留情。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3ea29491375, createdName=ms2000001231894997, createdTime=Thu Oct 10 22:57:21 CST 2024, time=2024-10-10, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=2229607, encodeId=2aab222960e2b, content=偏重的研究方向：肌肉减少症;临床 经验分享：记录一下，9.26投的，10.1变成with editor，今天10.7，还在with editor, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=33, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=8f372177652, createdName=1206696em63(暂无昵称), createdTime=Mon Oct 07 09:55:55 CST 2024, time=2024-10-07, status=1, ipAttribution=湖北省)]

2024-11-30 ms2000000373480608 来自上海

投稿命中率:25.0
偏重的研究方向：老年医学;分子机理
经验分享：2024.10.11投稿 with editor 2024.11.19 under review 到现在一点动静都没有……真的是所有投稿都送审吗……

7 5

展开5条回复

[GetPortalCommentsPageByObjectIdResponse(id=2237908, encodeId=9555223e90817, content=审稿速度:24.0 | 投稿命中率:25.0 偏重的研究方向：肌萎缩 经验分享：9.28投，10.10 with editor ，10.27催了，10.28回复在找审稿人，10.30又with editor 现在11.20 还是with editor什么情况。。。。到底要多久啊。。即将两个月, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=22, replyNumber=29, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ba1a8284909, createdName=ms3000001983661864, createdTime=Wed Nov 20 00:08:49 CST 2024, time=2024-11-20, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2238728, encodeId=3cde2238e28fd, content=一直 submitted 什么情况 11.15投的没变过, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=8, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b6e09260819, createdName=ms4000000384958423, createdTime=Sat Nov 23 19:21:58 CST 2024, time=2024-11-23, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2218493, encodeId=a36e2218493c2, content=偏重的研究方向：低肌肉质量;临床 经验分享：记录一下，8月2号投的，现在是 submit to journal, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=54, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=13995143031, createdName=1467de12m97暂无昵称, createdTime=Mon Aug 05 01:43:34 CST 2024, time=2024-08-05, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2240088, encodeId=54ab224008886, content=投稿命中率:25.0 偏重的研究方向：老年医学;分子机理 经验分享：2024.10.11投稿 with editor 2024.11.19 under review 到现在一点动静都没有……真的是所有投稿都送审吗……, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=7, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=68998321751, createdName=ms2000000373480608, createdTime=Sat Nov 30 18:53:30 CST 2024, time=2024-11-30, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2239393, encodeId=8d2e2239393f4, content=审稿速度:3.0 | 投稿命中率:50.0 经验分享：JCSM是一本中科院一区的顶级期刊，专注于恶病质、肌少症以及相关领域的研究。 审稿周期通常较长，平均需要16周左右的时间。 在提交稿件时，可以考虑附上一封详细的投稿信（个人觉得有点帮助） 要注意的是如大修，在修改时详细回复每项评论，并附上修改说明。 大家还了解哪些可以继续补充 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=30, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=520e8539624, createdName=ms2000001788822131, createdTime=Tue Nov 26 22:43:18 CST 2024, time=2024-11-26, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2239914, encodeId=2af52239914c2, content=审稿速度:12.0 | 投稿命中率:5.0 经验分享：3月份投稿 6月份大修 8月初修回到现在一直在UR 是什么情况会被拒稿吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=6, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/img/user_icon.png, createdBy=1e3e9045656, createdName=ms6000000691767799, createdTime=Fri Nov 29 13:08:07 CST 2024, time=2024-11-29, status=1, ipAttribution=新加坡), GetPortalCommentsPageByObjectIdResponse(id=2239303, encodeId=aabb2239303fc, content=审稿速度:3.0 偏重的研究方向：消化道肿瘤 经验分享：可怕这个杂志是所有文章都送审吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=7, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/img/user_icon.png, createdBy=1e3e9045656, createdName=ms6000000691767799, createdTime=Tue Nov 26 14:26:03 CST 2024, time=2024-11-26, status=1, ipAttribution=新加坡), GetPortalCommentsPageByObjectIdResponse(id=2238655, encodeId=f4f8223865586, content=审稿速度:3.0 | 投稿命中率:25.0 经验分享：投稿3个月了 UR时间都变了好几次了到底要多久才能回来, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=13, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/img/user_icon.png, createdBy=1e3e9045656, createdName=ms6000000691767799, createdTime=Sat Nov 23 13:38:13 CST 2024, time=2024-11-23, status=1, ipAttribution=新加坡), GetPortalCommentsPageByObjectIdResponse(id=2230225, encodeId=6e9d223022598, content=刚投稿，做的多中心的肌少症预测模型，希望审稿人手下留情。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3ea29491375, createdName=ms2000001231894997, createdTime=Thu Oct 10 22:57:21 CST 2024, time=2024-10-10, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=2229607, encodeId=2aab222960e2b, content=偏重的研究方向：肌肉减少症;临床 经验分享：记录一下，9.26投的，10.1变成with editor，今天10.7，还在with editor, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=33, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=8f372177652, createdName=1206696em63(暂无昵称), createdTime=Mon Oct 07 09:55:55 CST 2024, time=2024-10-07, status=1, ipAttribution=湖北省)]

2024-11-26 ms2000001788822131 来自上海

审稿速度:3.0 | 投稿命中率:50.0
经验分享：JCSM是一本中科院一区的顶级期刊，专注于恶病质、肌少症以及相关领域的研究。
审稿周期通常较长，平均需要16周左右的时间。
在提交稿件时，可以考虑附上一封详细的投稿信（个人觉得有点帮助）
要注意的是如大修，在修改时详细回复每项评论，并附上修改说明。
大家还了解哪些可以继续补充

30 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2237908, encodeId=9555223e90817, content=审稿速度:24.0 | 投稿命中率:25.0 偏重的研究方向：肌萎缩 经验分享：9.28投，10.10 with editor ，10.27催了，10.28回复在找审稿人，10.30又with editor 现在11.20 还是with editor什么情况。。。。到底要多久啊。。即将两个月, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=22, replyNumber=29, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ba1a8284909, createdName=ms3000001983661864, createdTime=Wed Nov 20 00:08:49 CST 2024, time=2024-11-20, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2238728, encodeId=3cde2238e28fd, content=一直 submitted 什么情况 11.15投的没变过, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=8, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b6e09260819, createdName=ms4000000384958423, createdTime=Sat Nov 23 19:21:58 CST 2024, time=2024-11-23, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2218493, encodeId=a36e2218493c2, content=偏重的研究方向：低肌肉质量;临床 经验分享：记录一下，8月2号投的，现在是 submit to journal, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=54, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=13995143031, createdName=1467de12m97暂无昵称, createdTime=Mon Aug 05 01:43:34 CST 2024, time=2024-08-05, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2240088, encodeId=54ab224008886, content=投稿命中率:25.0 偏重的研究方向：老年医学;分子机理 经验分享：2024.10.11投稿 with editor 2024.11.19 under review 到现在一点动静都没有……真的是所有投稿都送审吗……, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=7, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=68998321751, createdName=ms2000000373480608, createdTime=Sat Nov 30 18:53:30 CST 2024, time=2024-11-30, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2239393, encodeId=8d2e2239393f4, content=审稿速度:3.0 | 投稿命中率:50.0 经验分享：JCSM是一本中科院一区的顶级期刊，专注于恶病质、肌少症以及相关领域的研究。 审稿周期通常较长，平均需要16周左右的时间。 在提交稿件时，可以考虑附上一封详细的投稿信（个人觉得有点帮助） 要注意的是如大修，在修改时详细回复每项评论，并附上修改说明。 大家还了解哪些可以继续补充 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=30, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=520e8539624, createdName=ms2000001788822131, createdTime=Tue Nov 26 22:43:18 CST 2024, time=2024-11-26, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2239914, encodeId=2af52239914c2, content=审稿速度:12.0 | 投稿命中率:5.0 经验分享：3月份投稿 6月份大修 8月初修回到现在一直在UR 是什么情况会被拒稿吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=6, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/img/user_icon.png, createdBy=1e3e9045656, createdName=ms6000000691767799, createdTime=Fri Nov 29 13:08:07 CST 2024, time=2024-11-29, status=1, ipAttribution=新加坡), GetPortalCommentsPageByObjectIdResponse(id=2239303, encodeId=aabb2239303fc, content=审稿速度:3.0 偏重的研究方向：消化道肿瘤 经验分享：可怕这个杂志是所有文章都送审吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=7, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/img/user_icon.png, createdBy=1e3e9045656, createdName=ms6000000691767799, createdTime=Tue Nov 26 14:26:03 CST 2024, time=2024-11-26, status=1, ipAttribution=新加坡), GetPortalCommentsPageByObjectIdResponse(id=2238655, encodeId=f4f8223865586, content=审稿速度:3.0 | 投稿命中率:25.0 经验分享：投稿3个月了 UR时间都变了好几次了到底要多久才能回来, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=13, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/img/user_icon.png, createdBy=1e3e9045656, createdName=ms6000000691767799, createdTime=Sat Nov 23 13:38:13 CST 2024, time=2024-11-23, status=1, ipAttribution=新加坡), GetPortalCommentsPageByObjectIdResponse(id=2230225, encodeId=6e9d223022598, content=刚投稿，做的多中心的肌少症预测模型，希望审稿人手下留情。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3ea29491375, createdName=ms2000001231894997, createdTime=Thu Oct 10 22:57:21 CST 2024, time=2024-10-10, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=2229607, encodeId=2aab222960e2b, content=偏重的研究方向：肌肉减少症;临床 经验分享：记录一下，9.26投的，10.1变成with editor，今天10.7，还在with editor, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=33, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=8f372177652, createdName=1206696em63(暂无昵称), createdTime=Mon Oct 07 09:55:55 CST 2024, time=2024-10-07, status=1, ipAttribution=湖北省)]

2024-11-29 ms6000000691767799 来自新加坡

审稿速度:12.0 | 投稿命中率:5.0
经验分享：3月份投稿 6月份大修 8月初修回到现在一直在UR 是什么情况会被拒稿吗

6 2

展开2条回复

[GetPortalCommentsPageByObjectIdResponse(id=2237908, encodeId=9555223e90817, content=审稿速度:24.0 | 投稿命中率:25.0 偏重的研究方向：肌萎缩 经验分享：9.28投，10.10 with editor ，10.27催了，10.28回复在找审稿人，10.30又with editor 现在11.20 还是with editor什么情况。。。。到底要多久啊。。即将两个月, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=22, replyNumber=29, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ba1a8284909, createdName=ms3000001983661864, createdTime=Wed Nov 20 00:08:49 CST 2024, time=2024-11-20, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2238728, encodeId=3cde2238e28fd, content=一直 submitted 什么情况 11.15投的没变过, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=8, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b6e09260819, createdName=ms4000000384958423, createdTime=Sat Nov 23 19:21:58 CST 2024, time=2024-11-23, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2218493, encodeId=a36e2218493c2, content=偏重的研究方向：低肌肉质量;临床 经验分享：记录一下，8月2号投的，现在是 submit to journal, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=54, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=13995143031, createdName=1467de12m97暂无昵称, createdTime=Mon Aug 05 01:43:34 CST 2024, time=2024-08-05, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2240088, encodeId=54ab224008886, content=投稿命中率:25.0 偏重的研究方向：老年医学;分子机理 经验分享：2024.10.11投稿 with editor 2024.11.19 under review 到现在一点动静都没有……真的是所有投稿都送审吗……, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=7, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=68998321751, createdName=ms2000000373480608, createdTime=Sat Nov 30 18:53:30 CST 2024, time=2024-11-30, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2239393, encodeId=8d2e2239393f4, content=审稿速度:3.0 | 投稿命中率:50.0 经验分享：JCSM是一本中科院一区的顶级期刊，专注于恶病质、肌少症以及相关领域的研究。 审稿周期通常较长，平均需要16周左右的时间。 在提交稿件时，可以考虑附上一封详细的投稿信（个人觉得有点帮助） 要注意的是如大修，在修改时详细回复每项评论，并附上修改说明。 大家还了解哪些可以继续补充 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=30, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=520e8539624, createdName=ms2000001788822131, createdTime=Tue Nov 26 22:43:18 CST 2024, time=2024-11-26, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2239914, encodeId=2af52239914c2, content=审稿速度:12.0 | 投稿命中率:5.0 经验分享：3月份投稿 6月份大修 8月初修回到现在一直在UR 是什么情况会被拒稿吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=6, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/img/user_icon.png, createdBy=1e3e9045656, createdName=ms6000000691767799, createdTime=Fri Nov 29 13:08:07 CST 2024, time=2024-11-29, status=1, ipAttribution=新加坡), GetPortalCommentsPageByObjectIdResponse(id=2239303, encodeId=aabb2239303fc, content=审稿速度:3.0 偏重的研究方向：消化道肿瘤 经验分享：可怕这个杂志是所有文章都送审吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=7, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/img/user_icon.png, createdBy=1e3e9045656, createdName=ms6000000691767799, createdTime=Tue Nov 26 14:26:03 CST 2024, time=2024-11-26, status=1, ipAttribution=新加坡), GetPortalCommentsPageByObjectIdResponse(id=2238655, encodeId=f4f8223865586, content=审稿速度:3.0 | 投稿命中率:25.0 经验分享：投稿3个月了 UR时间都变了好几次了到底要多久才能回来, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=13, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/img/user_icon.png, createdBy=1e3e9045656, createdName=ms6000000691767799, createdTime=Sat Nov 23 13:38:13 CST 2024, time=2024-11-23, status=1, ipAttribution=新加坡), GetPortalCommentsPageByObjectIdResponse(id=2230225, encodeId=6e9d223022598, content=刚投稿，做的多中心的肌少症预测模型，希望审稿人手下留情。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3ea29491375, createdName=ms2000001231894997, createdTime=Thu Oct 10 22:57:21 CST 2024, time=2024-10-10, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=2229607, encodeId=2aab222960e2b, content=偏重的研究方向：肌肉减少症;临床 经验分享：记录一下，9.26投的，10.1变成with editor，今天10.7，还在with editor, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=33, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=8f372177652, createdName=1206696em63(暂无昵称), createdTime=Mon Oct 07 09:55:55 CST 2024, time=2024-10-07, status=1, ipAttribution=湖北省)]

2024-11-26 ms6000000691767799 来自新加坡

审稿速度:3.0
偏重的研究方向：消化道肿瘤
经验分享：可怕这个杂志是所有文章都送审吗

7 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2237908, encodeId=9555223e90817, content=审稿速度:24.0 | 投稿命中率:25.0 偏重的研究方向：肌萎缩 经验分享：9.28投，10.10 with editor ，10.27催了，10.28回复在找审稿人，10.30又with editor 现在11.20 还是with editor什么情况。。。。到底要多久啊。。即将两个月, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=22, replyNumber=29, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ba1a8284909, createdName=ms3000001983661864, createdTime=Wed Nov 20 00:08:49 CST 2024, time=2024-11-20, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2238728, encodeId=3cde2238e28fd, content=一直 submitted 什么情况 11.15投的没变过, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=8, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b6e09260819, createdName=ms4000000384958423, createdTime=Sat Nov 23 19:21:58 CST 2024, time=2024-11-23, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2218493, encodeId=a36e2218493c2, content=偏重的研究方向：低肌肉质量;临床 经验分享：记录一下，8月2号投的，现在是 submit to journal, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=54, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=13995143031, createdName=1467de12m97暂无昵称, createdTime=Mon Aug 05 01:43:34 CST 2024, time=2024-08-05, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2240088, encodeId=54ab224008886, content=投稿命中率:25.0 偏重的研究方向：老年医学;分子机理 经验分享：2024.10.11投稿 with editor 2024.11.19 under review 到现在一点动静都没有……真的是所有投稿都送审吗……, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=7, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=68998321751, createdName=ms2000000373480608, createdTime=Sat Nov 30 18:53:30 CST 2024, time=2024-11-30, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2239393, encodeId=8d2e2239393f4, content=审稿速度:3.0 | 投稿命中率:50.0 经验分享：JCSM是一本中科院一区的顶级期刊，专注于恶病质、肌少症以及相关领域的研究。 审稿周期通常较长，平均需要16周左右的时间。 在提交稿件时，可以考虑附上一封详细的投稿信（个人觉得有点帮助） 要注意的是如大修，在修改时详细回复每项评论，并附上修改说明。 大家还了解哪些可以继续补充 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=30, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=520e8539624, createdName=ms2000001788822131, createdTime=Tue Nov 26 22:43:18 CST 2024, time=2024-11-26, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2239914, encodeId=2af52239914c2, content=审稿速度:12.0 | 投稿命中率:5.0 经验分享：3月份投稿 6月份大修 8月初修回到现在一直在UR 是什么情况会被拒稿吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=6, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/img/user_icon.png, createdBy=1e3e9045656, createdName=ms6000000691767799, createdTime=Fri Nov 29 13:08:07 CST 2024, time=2024-11-29, status=1, ipAttribution=新加坡), GetPortalCommentsPageByObjectIdResponse(id=2239303, encodeId=aabb2239303fc, content=审稿速度:3.0 偏重的研究方向：消化道肿瘤 经验分享：可怕这个杂志是所有文章都送审吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=7, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/img/user_icon.png, createdBy=1e3e9045656, createdName=ms6000000691767799, createdTime=Tue Nov 26 14:26:03 CST 2024, time=2024-11-26, status=1, ipAttribution=新加坡), GetPortalCommentsPageByObjectIdResponse(id=2238655, encodeId=f4f8223865586, content=审稿速度:3.0 | 投稿命中率:25.0 经验分享：投稿3个月了 UR时间都变了好几次了到底要多久才能回来, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=13, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/img/user_icon.png, createdBy=1e3e9045656, createdName=ms6000000691767799, createdTime=Sat Nov 23 13:38:13 CST 2024, time=2024-11-23, status=1, ipAttribution=新加坡), GetPortalCommentsPageByObjectIdResponse(id=2230225, encodeId=6e9d223022598, content=刚投稿，做的多中心的肌少症预测模型，希望审稿人手下留情。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3ea29491375, createdName=ms2000001231894997, createdTime=Thu Oct 10 22:57:21 CST 2024, time=2024-10-10, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=2229607, encodeId=2aab222960e2b, content=偏重的研究方向：肌肉减少症;临床 经验分享：记录一下，9.26投的，10.1变成with editor，今天10.7，还在with editor, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=33, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=8f372177652, createdName=1206696em63(暂无昵称), createdTime=Mon Oct 07 09:55:55 CST 2024, time=2024-10-07, status=1, ipAttribution=湖北省)]

2024-11-23 ms6000000691767799 来自新加坡

审稿速度:3.0 | 投稿命中率:25.0
经验分享：投稿3个月了 UR时间都变了好几次了到底要多久才能回来

13 2

展开2条回复

[GetPortalCommentsPageByObjectIdResponse(id=2237908, encodeId=9555223e90817, content=审稿速度:24.0 | 投稿命中率:25.0 偏重的研究方向：肌萎缩 经验分享：9.28投，10.10 with editor ，10.27催了，10.28回复在找审稿人，10.30又with editor 现在11.20 还是with editor什么情况。。。。到底要多久啊。。即将两个月, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=22, replyNumber=29, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ba1a8284909, createdName=ms3000001983661864, createdTime=Wed Nov 20 00:08:49 CST 2024, time=2024-11-20, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2238728, encodeId=3cde2238e28fd, content=一直 submitted 什么情况 11.15投的没变过, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=8, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b6e09260819, createdName=ms4000000384958423, createdTime=Sat Nov 23 19:21:58 CST 2024, time=2024-11-23, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2218493, encodeId=a36e2218493c2, content=偏重的研究方向：低肌肉质量;临床 经验分享：记录一下，8月2号投的，现在是 submit to journal, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=54, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=13995143031, createdName=1467de12m97暂无昵称, createdTime=Mon Aug 05 01:43:34 CST 2024, time=2024-08-05, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2240088, encodeId=54ab224008886, content=投稿命中率:25.0 偏重的研究方向：老年医学;分子机理 经验分享：2024.10.11投稿 with editor 2024.11.19 under review 到现在一点动静都没有……真的是所有投稿都送审吗……, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=7, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=68998321751, createdName=ms2000000373480608, createdTime=Sat Nov 30 18:53:30 CST 2024, time=2024-11-30, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2239393, encodeId=8d2e2239393f4, content=审稿速度:3.0 | 投稿命中率:50.0 经验分享：JCSM是一本中科院一区的顶级期刊，专注于恶病质、肌少症以及相关领域的研究。 审稿周期通常较长，平均需要16周左右的时间。 在提交稿件时，可以考虑附上一封详细的投稿信（个人觉得有点帮助） 要注意的是如大修，在修改时详细回复每项评论，并附上修改说明。 大家还了解哪些可以继续补充 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=30, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=520e8539624, createdName=ms2000001788822131, createdTime=Tue Nov 26 22:43:18 CST 2024, time=2024-11-26, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2239914, encodeId=2af52239914c2, content=审稿速度:12.0 | 投稿命中率:5.0 经验分享：3月份投稿 6月份大修 8月初修回到现在一直在UR 是什么情况会被拒稿吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=6, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/img/user_icon.png, createdBy=1e3e9045656, createdName=ms6000000691767799, createdTime=Fri Nov 29 13:08:07 CST 2024, time=2024-11-29, status=1, ipAttribution=新加坡), GetPortalCommentsPageByObjectIdResponse(id=2239303, encodeId=aabb2239303fc, content=审稿速度:3.0 偏重的研究方向：消化道肿瘤 经验分享：可怕这个杂志是所有文章都送审吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=7, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/img/user_icon.png, createdBy=1e3e9045656, createdName=ms6000000691767799, createdTime=Tue Nov 26 14:26:03 CST 2024, time=2024-11-26, status=1, ipAttribution=新加坡), GetPortalCommentsPageByObjectIdResponse(id=2238655, encodeId=f4f8223865586, content=审稿速度:3.0 | 投稿命中率:25.0 经验分享：投稿3个月了 UR时间都变了好几次了到底要多久才能回来, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=13, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/img/user_icon.png, createdBy=1e3e9045656, createdName=ms6000000691767799, createdTime=Sat Nov 23 13:38:13 CST 2024, time=2024-11-23, status=1, ipAttribution=新加坡), GetPortalCommentsPageByObjectIdResponse(id=2230225, encodeId=6e9d223022598, content=刚投稿，做的多中心的肌少症预测模型，希望审稿人手下留情。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3ea29491375, createdName=ms2000001231894997, createdTime=Thu Oct 10 22:57:21 CST 2024, time=2024-10-10, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=2229607, encodeId=2aab222960e2b, content=偏重的研究方向：肌肉减少症;临床 经验分享：记录一下，9.26投的，10.1变成with editor，今天10.7，还在with editor, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=33, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=8f372177652, createdName=1206696em63(暂无昵称), createdTime=Mon Oct 07 09:55:55 CST 2024, time=2024-10-07, status=1, ipAttribution=湖北省)]

2024-10-10 ms2000001231894997 来自福建省

刚投稿，做的多中心的肌少症预测模型，希望审稿人手下留情。

35 2

展开2条回复

[GetPortalCommentsPageByObjectIdResponse(id=2237908, encodeId=9555223e90817, content=审稿速度:24.0 | 投稿命中率:25.0 偏重的研究方向：肌萎缩 经验分享：9.28投，10.10 with editor ，10.27催了，10.28回复在找审稿人，10.30又with editor 现在11.20 还是with editor什么情况。。。。到底要多久啊。。即将两个月, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=22, replyNumber=29, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ba1a8284909, createdName=ms3000001983661864, createdTime=Wed Nov 20 00:08:49 CST 2024, time=2024-11-20, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2238728, encodeId=3cde2238e28fd, content=一直 submitted 什么情况 11.15投的没变过, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=8, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b6e09260819, createdName=ms4000000384958423, createdTime=Sat Nov 23 19:21:58 CST 2024, time=2024-11-23, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2218493, encodeId=a36e2218493c2, content=偏重的研究方向：低肌肉质量;临床 经验分享：记录一下，8月2号投的，现在是 submit to journal, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=54, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=13995143031, createdName=1467de12m97暂无昵称, createdTime=Mon Aug 05 01:43:34 CST 2024, time=2024-08-05, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2240088, encodeId=54ab224008886, content=投稿命中率:25.0 偏重的研究方向：老年医学;分子机理 经验分享：2024.10.11投稿 with editor 2024.11.19 under review 到现在一点动静都没有……真的是所有投稿都送审吗……, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=7, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=68998321751, createdName=ms2000000373480608, createdTime=Sat Nov 30 18:53:30 CST 2024, time=2024-11-30, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2239393, encodeId=8d2e2239393f4, content=审稿速度:3.0 | 投稿命中率:50.0 经验分享：JCSM是一本中科院一区的顶级期刊，专注于恶病质、肌少症以及相关领域的研究。 审稿周期通常较长，平均需要16周左右的时间。 在提交稿件时，可以考虑附上一封详细的投稿信（个人觉得有点帮助） 要注意的是如大修，在修改时详细回复每项评论，并附上修改说明。 大家还了解哪些可以继续补充 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=30, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=520e8539624, createdName=ms2000001788822131, createdTime=Tue Nov 26 22:43:18 CST 2024, time=2024-11-26, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2239914, encodeId=2af52239914c2, content=审稿速度:12.0 | 投稿命中率:5.0 经验分享：3月份投稿 6月份大修 8月初修回到现在一直在UR 是什么情况会被拒稿吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=6, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/img/user_icon.png, createdBy=1e3e9045656, createdName=ms6000000691767799, createdTime=Fri Nov 29 13:08:07 CST 2024, time=2024-11-29, status=1, ipAttribution=新加坡), GetPortalCommentsPageByObjectIdResponse(id=2239303, encodeId=aabb2239303fc, content=审稿速度:3.0 偏重的研究方向：消化道肿瘤 经验分享：可怕这个杂志是所有文章都送审吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=7, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/img/user_icon.png, createdBy=1e3e9045656, createdName=ms6000000691767799, createdTime=Tue Nov 26 14:26:03 CST 2024, time=2024-11-26, status=1, ipAttribution=新加坡), GetPortalCommentsPageByObjectIdResponse(id=2238655, encodeId=f4f8223865586, content=审稿速度:3.0 | 投稿命中率:25.0 经验分享：投稿3个月了 UR时间都变了好几次了到底要多久才能回来, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=13, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/img/user_icon.png, createdBy=1e3e9045656, createdName=ms6000000691767799, createdTime=Sat Nov 23 13:38:13 CST 2024, time=2024-11-23, status=1, ipAttribution=新加坡), GetPortalCommentsPageByObjectIdResponse(id=2230225, encodeId=6e9d223022598, content=刚投稿，做的多中心的肌少症预测模型，希望审稿人手下留情。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3ea29491375, createdName=ms2000001231894997, createdTime=Thu Oct 10 22:57:21 CST 2024, time=2024-10-10, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=2229607, encodeId=2aab222960e2b, content=偏重的研究方向：肌肉减少症;临床 经验分享：记录一下，9.26投的，10.1变成with editor，今天10.7，还在with editor, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=33, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=8f372177652, createdName=1206696em63(暂无昵称), createdTime=Mon Oct 07 09:55:55 CST 2024, time=2024-10-07, status=1, ipAttribution=湖北省)]

2024-10-07 1206696em63(暂无昵称) 来自湖北省

偏重的研究方向：肌肉减少症;临床
经验分享：记录一下，9.26投的，10.1变成with editor，今天10.7，还在with editor

33 4

展开4条回复

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

期刊讨论

科室

工具

服务